Silodosin versus naftopidil in the treatment of premature ejaculation: A prospective multicenter trial.

about

Silodosin versus naftopidil in the treatment of premature ejaculation: A prospective multicenter trial.

Item

http://www.wikidata.org/entity/Q48631981

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Silodosin versus naftopidil in ...... prospective multicenter trial.

@en

Silodosin versus naftopidil in ...... prospective multicenter trial.

@nl

type

Item

label

Silodosin versus naftopidil in ...... prospective multicenter trial.

@en

Silodosin versus naftopidil in ...... prospective multicenter trial.

@nl

prefLabel

Silodosin versus naftopidil in ...... prospective multicenter trial.

@en

Silodosin versus naftopidil in ...... prospective multicenter trial.

@nl

P1476

Silodosin versus naftopidil in ...... prospective multicenter trial.

@en

P2093

Ichiya Honma

http://www.w3.org/2001/XMLSchema#string

Kazunori Haga

http://www.w3.org/2001/XMLSchema#string

Kousuke Uchida

http://www.w3.org/2001/XMLSchema#string

Masanori Matsukawa

http://www.w3.org/2001/XMLSchema#string

Musashi Tobe

http://www.w3.org/2001/XMLSchema#string

Nobuyuki Kondou

http://www.w3.org/2001/XMLSchema#string

Tohru Araki

http://www.w3.org/2001/XMLSchema#string

Toshikazu Otani

http://www.w3.org/2001/XMLSchema#string

Toshiyasu Amano

http://www.w3.org/2001/XMLSchema#string

Yoshikazu Sato

http://www.w3.org/2001/XMLSchema#string

P2860

Orgasm is preserved regardless of ejaculatory dysfunction with selective alpha1A-blocker administration

The pathophysiology of acquired premature ejaculation

The drug treatment of premature ejaculation

An Update of the International Society of Sexual Medicine's Guidelines for the Diagnosis and Treatment of Premature Ejaculation (PE).

Inhibition of Seminal emission is the main cause of anejaculation induced by a new highly selective alpha1A-blocker in normal volunteers.

Epidemiology of premature ejaculation.

Silodosin therapy for lower urinary tract symptoms in men with suspected benign prostatic hyperplasia: results of an international, randomized, double-blind, placebo- and active-controlled clinical trial performed in Europe.

Evaluation of premature ejaculation.

Men's health: sexual dysfunction, physical, and psychological health--is there a link?

Comparison of alpha blockers in treatment of premature ejaculation: a pilot clinical trial.

P304

626-631

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJU.13392

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28627033

http://www.w3.org/2001/XMLSchema#string